Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Europe midday: Stocks rise ahead of key US inflation data
(Sharecast News) - Strong gains from tech stocks, as well as heavyweights Tesco and Philips, were providing a lift on European equity markets on Wednesday, with investors in a positive mood ahead of a key inflation report from across the Pond. The 'stickiness' of inflation over the past two months has sparked concerns on financial markets that the Federal Reserve may hold off from cutting interest rates for longer than anticipated, while the recent surge in oil prices has added upwards pressure on the price outlook. The US consumer price index for March is due out at 1430 CEST and is expected to show that the annual inflation rate rose to 3.4% from 3.2% in February.
Nevertheless, despite the nervousness surrounding the report, stocks were bouncing back after losses on Tuesday, with the Stoxx 600 up 0.6% by lunchtime, with markets across the continent making gains of around 0.4% to 0.8%.
"Investors have been dialling back expectations for a June cut by the Fed - the market action yesterday suggests caution ahead of the number," said Neil Wilson, chief market analyst at Finalto.
Asian markets were mostly higher overnight despite the news that Fitch Ratings has cut its outlook on China to 'negative' on the back of the country's increasingly uncertain economic prospects. The rating agency said it had revised the outlook on China's long-term foreign currency issuer default rating (IDR) to 'negative' from 'stable'. It affirmed the IDR at 'A+'.
"However, analysts believe that the downgrade does not accurately reflect the future performance of the economy," said Manoj Ladwa, director at ARJ Capital.
Back in Europe, no major economic data was due for release, with eyes starting to turn towards Thursday's European Central Bank meeting, though no change in policy is expected.
"While [ECB chief Christine] Lagarde will likely continue to make a clear case for a June cut, she will likely come short of explicitly calling for one or give any concrete guidance about the potential pace of rate cuts," according to analysts at TD Securities.
Market movers
Tech stocks across the continent were performing well after positive results from Taiwan semiconductor group TSMC, the world's largest contract chipmaker, with first-quarter revenues rising by more than forecasts. ASML and STMicroelectronics were among the best performers in Europe.
Chocolate company Barry Callebaut jumped 8% in Zurich despite missing forecasts with a 40% drop in first-half profits, though revenues were 11% higher on the back of rising cocoa prices.
UK retail giant Tesco rose 5% after its annual results showed statutory pre-tax profits were up 160% in 2023 as sales jumped 7.2% on the back of a growing market share. Chief executive Ken Murpphy noted that "inflationary pressures have lessened substantially".
Also in London, easyJet was flying 2% higher after the budget airline concluded negotiations with the Unite union over cabin crew salaries, agreeing to a 20% increase in basic pay.
Philips was also performing well, rising 3% in Amsterdam after settling on a consent decree with the DOJ and FDA regarding its the sleep and respiratory care devices under the Respironics brand. The Dutch conglomerate said the agreement "provides clarity and a roadmap to [...] restore the Philips Respironics business", following a recall of respiratory devices in 2021.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.